Facility 1

Minneapolis, Minnesota 55407

0 studies enrolling now · 2 studies all time

What they study most

Breast Neoplasm, Thyroid Cancer

Studies at this site

• A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Trial of Lenvatinib (E7080) in 131I-Refractory Differentiated Thyroid Cancer (DTC) — Completed
• Study to Evaluate the Efficacy and Safety of Eribulin Mesylate in Combination With Pembrolizumab in Participants With Metastatic Triple-Negative Breast Cancer (mTNBC) — Completed